ResultsIQ

ResultsIQ › Latest results › Zydus Wellness Limited

Zydus Wellness Limited Q2 FY27 results deck summary

NSE: ZYDUSWELL · BSE: 531335

Results deck of 3 Nov 2026, summarised by AI from the filing.

Zydus Wellness Q2 FY27 net sales rose 74.6% to ₹11,227 million and EBITDA 271.7% to ₹855 million, helped by the Comfort Click acquisition.

Key takeaways

  1. Net sales Q2 FY27 net sales were ₹11,227 million (Q2 FY26: ₹6,429 million, +74.6%) and H1 FY27 ₹25,526 million (+70.1%).
  2. Gross margin Q2 FY27 gross contribution was 61.1% of net sales (Q2 FY26: 52.4%, +870 bps), helped by the higher-margin Comfort Click business.
  3. EBITDA Q2 FY27 EBITDA was ₹855 million (Q2 FY26: ₹230 million, +271.7%) at a 7.6% margin versus 3.5%.
  4. Finance cost Interest on the Euro-denominated loan funding the Comfort Click acquisition sits in finance costs, and brand amortization raised depreciation.

Original filing on BSE

Zydus Wellness Limited Q2 FY27 results

As filed: Revenue ₹1,127 cr (+73% year on year), EBITDA ₹85.5 cr (+272% year on year), PAT ₹5.1 cr, EBITDA margin 7.6% (+406 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹1,437 cr (+67% year on year), EBITDA ₹242 cr (+55% year on year), PAT ₹119 cr (−7% year on year), EBITDA margin 16.8% (−130 bps). Score 55 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 130 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −3.9% in 30 days (Nifty 500: −2.3%).
  • Q4 FY26: Revenue ₹1,485 cr (+63% year on year), EBITDA ₹270 cr (+43% year on year), PAT ₹162 cr (−6% year on year), EBITDA margin 18.2% (−251 bps). Score 58 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 251 bps year on year. Tax rate 9%. Consolidated profit -6% but standalone +166%. Revenue rose ₹572 cr on a year ago, more than the ₹130 cr it added the year before. Share price after the results: +0.8% in 30 days (Nifty 500: +2.6%).
  • Q3 FY26: Revenue ₹965 cr (+109% year on year), EBITDA ₹61.0 cr (+300% year on year), PAT −₹39.9 cr (−300% year on year), EBITDA margin 6.3% (+329 bps). Score 20 of 100, Below trend. Revenue and EBITDA growth were well above the company's own trend; profit before exceptional items growth was well below it. EBITDA margin rose 329 bps year on year. Consolidated profit -765% but standalone +1%. Share price after the results: −12.0% in 30 days (Nifty 500: −0.6%).
  • Q2 FY26: Revenue ₹651 cr (+32% year on year), EBITDA ₹23.0 cr (+15% year on year), PAT −₹53.0 cr (−194% year on year), EBITDA margin 3.5% (−52 bps). Score 20 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit before exceptional items growth was well below it. EBITDA margin fell 52 bps year on year. Consolidated profit -352% but standalone +0%. Revenue fell 24% from last quarter. Share price after the results: −11.5% in 30 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹861 cr (+2% year on year), EBITDA ₹156 cr (0% year on year), PAT ₹128 cr (−14% year on year), EBITDA margin 18.1% (−43 bps). Score 28 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin fell 43 bps year on year. Tax rate 12%. Consolidated profit -14% but standalone +17%. Revenue fell 6% from last quarter. Share price after the results: +0.3% in 30 days (Nifty 500: −2.4%).
  • Q4 FY25: Revenue ₹913 cr (+17% year on year), EBITDA ₹189 cr (+17% year on year), PAT ₹172 cr (+15% year on year), EBITDA margin 20.7% (+1 bps). Score 61 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was in line with it. EBITDA margin was flat year on year. Tax rate 1%. Consolidated profit +15% but standalone -29%. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +12.1% in 30 days (Nifty 500: +0.3%).
  • Q3 FY25: Revenue ₹462 cr (+15% year on year), EBITDA ₹14.0 cr (+8% year on year), PAT ₹6.0 cr, EBITDA margin 3.0% (−20 bps). Score 46 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it. EBITDA margin fell 20 bps year on year. Other income 40% of PBT. Tax rate 40%. Revenue fell 6% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Zydus Wellness Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.